Home Telemonitoring for Patients With Lung Cancer
HTPLC
PILOT: Home Telemonitoring for Self-Management Education of Patients With Lung Ca
2 other identifiers
interventional
47
1 country
1
Brief Summary
The purpose of this study is to learn more about using a home machine "Telemonitor" to find problems people with lung cancer may have after being discharged from the hospital and help them manage problems by contacting their healthcare provider.The study hypothesis is that patients with lung CA using short-term (14 days)home telemonitors, educated/coached by nurses on telemonitor data risks/implications for the first two weeks after hospital discharge, will be able to self-report their signs/ symptoms to the clinician resulting in decreased use of costly health care resources over 60 days.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable lung-cancer
Started Apr 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2011
CompletedFirst Submitted
Initial submission to the registry
August 9, 2012
CompletedFirst Posted
Study publicly available on registry
August 22, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedResults Posted
Study results publicly available
January 20, 2022
CompletedOctober 18, 2022
December 1, 2021
1.7 years
August 9, 2012
August 11, 2021
September 23, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Changes in Telemonitor Data From Baseline: Temperature
Changes in temperature measured by telemonitor daily over 14 days after hospital discharge
14 days
Changes in Telemonitor Data From Baseline: Pulse Rate
Changes in pulse rate measured by telemonitor daily over 14 days after hospital discharge
14 days
Changes in Telemonitor Data From Baseline: Blood Pressure
Changes in blood pressure measured by telemonitor daily over 14 days after hospital discharge
14 days
Changes in Telemonitor Data From Baseline: SpO2
Changes in SpO2 measured by telemonitor daily over 14 days after hospital discharge
14 days
Changes in Telemonitor Data From Baseline: Weight
Changes in weight measured by telemonitor daily over 14 days after hospital discharge
14 days
Secondary Outcomes (3)
Changes in Telemonitor Symptoms Recorded From Baseline: Dyspnea
14 days
Changes in Telemonitor Symptoms Recorded From Baseline: Functioning
14 days
Changes in Telemonitor Symptoms Recorded From Baseline: Pain
14 days
Study Arms (2)
Telemonitor
EXPERIMENTALIn addition to routine care, the "HomMed Telemonitor" wireless telemonitoring system (intervention)will be used in the patient's home for 14 days to alert the clinical research nurse to changes in patients conditions in order to contact them to teach self-management. The Honeywell HomMed Genesis™ DM Remote Patient Care Monitor will be used to measure temperature, pulse, oxygen level,weight and blood pressure. The telemonitor will also ask for a YES or NO response to questions on symptoms such as difficulty breathing. Research nurses review the data daily and call the participant for 2 weeks, and continue to monitor outcomes for 2 months.
Routine care for patients with lungCa
NO INTERVENTIONTraditional physician ordered post-hospital care for patients with lung CA in rural WV requires patients to make an outpatient office/ clinic visit two to three weeks after discharge;a few patients receive homecare service referrals. No attempt to change care - just monitor what is used and collect study data at Discharge, 2 weeks, one month and two months.
Interventions
A "HomMed Telemonitor" wireless telemonitoring system collects data on a daily basis, including heart rate, blood pressure, oxygen level, body temperature, weight, responses to 9 pre-programmed questions (including difficulty breathing, fatigue, limited activities, difficulty taking meds, pain). Telemonitored results are transmitted to the research office for analysis and contact to patient by clinical research nurses.
Eligibility Criteria
You may qualify if:
- (1) patients admitted to the hospital for lung CA as a primary or secondary diagnosis; (2) at least 45 years of age and up to 90 years old; (3) stable mental status and ability to speak (but not necessarily read) the primary language of the region (English).
You may not qualify if:
- are not discharged to home settings
- are discharged to hospice
- display a verbalized inability to understand or answer the questionnaires, (4) are disqualified at the discretion of the treating physician, and/or (4) live beyond a 75 mile radius of the hospital.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- West Virginia Universitylead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
WVU Mary Babb Randolph Cancer Center and Ruby Hospital
Morgantown, West Virginia, 26506, United States
Related Publications (3)
Chen YJ, Narsavage GL, Culp SL, Weaver TE. The development and psychometric analysis of the short-form Pulmonary Functional Status Scale (PFSS-11). Res Nurs Health. 2010 Dec;33(6):477-85. doi: 10.1002/nur.20403. Epub 2010 Oct 18.
PMID: 20957666BACKGROUNDNarsavage G, Romeo E. Education and support needs of younger and older cancer survivors. Appl Nurs Res. 2003 May;16(2):103-9. doi: 10.1016/s0897-1897(03)00008-9.
PMID: 12764721BACKGROUNDNarsavage GL, Naylor MD. Factors associated with referral of elderly individuals with cardiac and pulmonary disorders for home care services following hospital discharge. J Gerontol Nurs. 2000 May;26(5):14-20. doi: 10.3928/0098-9134-20000501-08.
PMID: 11111516BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Georgia L Narsavage
- Organization
- West Virginia University
Study Officials
- PRINCIPAL INVESTIGATOR
Georgia L Narsavage, PhD, MSN
West Virginia University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 9, 2012
First Posted
August 22, 2012
Study Start
April 1, 2011
Primary Completion
December 1, 2012
Study Completion
June 1, 2013
Last Updated
October 18, 2022
Results First Posted
January 20, 2022
Record last verified: 2021-12